Iman Hamadeh

Title: **Iman Hamadeh: Pioneering Cancer Detection Technology in Göteborg**

Introduction

Iman Hamadeh, an innovative inventor based in Göteborg, Sweden, has made significant contributions to the field of medical technology. With a focus on advancing cancer detection methods, she has been instrumental in developing systems that enhance diagnostic accuracy, particularly in identifying bone cancer metastases.

Latest Patents

Iman holds two notable patents, both related to her groundbreaking work on cancer detection systems. Her latest patent is a **System for Detecting Bone Cancer Metastases**, which comprises a sophisticated detection system designed to automatically identify bone cancer metastases from a series of isotope bone scan images of a patient's skeleton. This innovative system includes a shape identifier unit, a hotspot detection unit, a hotspot feature extraction unit, a first artificial neural network unit, a patient feature extraction unit, and a second artificial neural network unit. This invention holds the potential to revolutionize how physicians diagnose and treat bone cancer, providing timely and accurate detection.

Career Highlights

Iman Hamadeh has built a robust career at Exini Diagnostics AB, where she applies her expertise to develop advanced medical imaging technologies. Her work is characterized by a commitment to improving patient outcomes through innovative diagnostic tools. As a professional at the intersection of technology and healthcare, Iman continues to drive forward the frontiers of medical research and development.

Collaborations

At Exini Diagnostics AB, Iman collaborates with a talented team that includes her coworkers Pierre Nordblom and Karl Sjöstrand. This collaboration enhances the inventive process, enabling the team to combine their diverse skills and knowledge in the quest to create state-of-the-art cancer detection technologies.

Conclusion

Iman Hamadeh is an exemplary figure in the realm of medical inventions, particularly in the field of cancer detection. Her patents represent significant advancements that could lead to earlier and more accurate diagnoses of bone cancer metastases. As she continues her work at Exini Diagnostics AB, Iman's innovations promise to have a lasting impact on medical technology and patient care.